Physician profile

Neil Kumar Singla

Anesthesiology · Pasadena, CA

NPI 1144371402

$52,289.69

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$23,413.75
Travel and Lodging$300.00
Food and Beverage$131.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $24,618.73 2019-2024
Alkermes, INC. $11,247.47 2019-2020
Eli Lilly and Company $7,200.00 2020
Tris Pharma INC $3,631.11 2023
Davol INC. $3,018.75 2024
Vertex Pharmaceuticals Incorporated $2,515.00 2019-2022
Pacira Pharmaceuticals Incorporated $31.91 2020
Mallinckrodt Enterprises LLC $26.72 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Neil Kumar Singla

$52,289.69

in general payments reported 2019-2025

Years
2019-2024
Top company
Merck Sharp & Dohme LLC

https://glasscript.com/doctor/188225/neil-kumar-singla

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.